The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Activity of cabazitaxel in temozolomide refractory glioblastoma: Final results of a phase 2 study (C-GBM study; EudraCT 2013-001550-98 NCT 01866449).
 
Bernhard Heinrich
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Roche; Sanofi
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)
 
Richard F Schlenk
No Relationships to Disclose
 
Olaf Lothar Brudler
No Relationships to Disclose
 
Simone Edenhofer
No Relationships to Disclose
 
Angelika Scheuerle
No Relationships to Disclose
 
Ralph Naumann
Speakers' Bureau - Amgen; Celgene
 
Regine Mayer-Steinacker
No Relationships to Disclose
 
Markus Bangerter
No Relationships to Disclose
 
Lars Bullinger
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Novartis
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Celgene